Advertisement

Latest News

Atul Malhotra, MD: Tirzepatide for Obstructive Sleep Apnea and Obesity

24 minutes ago

Atul Malhotra, MD, discusses the results of the SURMOUNT-OSA trial and how they inform clinicians on the role of tirzepatide in OSA and obesity.

SURMOUNT-OSA: Tirzepatide Cuts Obstructive Sleep Apnea Severity by 30 Events/Hour

26 minutes ago

Tirzepatide reduces OSA severity by 30 events/hour and achieves remission in up to 51% of patients with obesity, per SURMOUNT-OSA study results from Eli Lilly and Company.

Fenofibrate Markedly Lowers Progression of Diabetic Retinopathy

26 minutes ago

A first-time trial presented at ADA 2024 found the common cholesterol-lowering drug halts vision loss in patients with diabetic eye disease.

Resources Available for Patients with HIV Drug Resistance

1 hour ago

The panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.

Alpha-1 Antitrypsin Therapy Does Not Improve C-Peptide in Chronic Pancreatitis

1 hour ago

Although AAT therapy was found to be well-tolerable, the infusions did not improve C-peptide AUC in patients with chronic pancreatitis undergoing TP-IAT.

Advertisement
Advertisement